ABCL
Ticker
AbCellera Biologics Inc.
ABCL · Healthcare · AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the Unit…AbCellera Biologics Inc. (ABCL), in the Healthcare sector, has 7 disclosed filings on Paydirt over the trailing twelve months from 4 corporate insiders: 7 purchases and 0 sales. Filers took a median of 0 days from execution to disclosure, and the most recent trade was executed Aug 18 and filed Aug 18. The most active filer was John S. Montalbano with 3 filings.
Add to watchlistFilings, ttm
7
7 buys · 0 sells
Traders, ttm
4
4 insiders
Volume, ttmiDollar value disclosed in the window
$2.0M
estimated for Congress, as filed for insiders
Median delay
0d
execution to disclosure
Last traded
Aug 18
Filed Aug 18
ADViAverage daily dollar volume
$89.1M
market data
Share price · 12M
$11.39 (+135.7%)
Adjusted for splits and dividends.
Volume by month
Buys $2.9M
Sells $0
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
JMRecent filings
John S. MontalbanoPURCHASE
Director
$110K10,000 sh × $11.03
Exec Aug 18
Filed Aug 18 · 2:45 PM ET Andrew BoothPURCHASE Chief Financial Officer $384K
37,200 sh × $10.32
Exec Aug 14
Filed Aug 14 · 12:04 PM ET Michael R HaydenPURCHASE Director $481K
46,387 sh × $10.37
Exec Aug 12
Filed Aug 14 · 11:50 AM ET Thermopylae Holdings Ltd.PURCHASE 10% owner $131K
38,000 sh × $3.44
Exec Feb 27
Filed Mar 2 · 2:16 PM ET Thermopylae Holdings Ltd.PURCHASE 10% owner $580K
177,457 sh × $3.27
Exec Feb 26
Filed Feb 27 · 4:20 PM ET Andrew BoothPURCHASE Chief Financial Officer $146K
42,600 sh × $3.42
Exec Feb 27
Filed Feb 27 · 2:48 PM ET John S. MontalbanoPURCHASE Director $178K
50,000 sh × $3.57
Exec Nov 26 2025
Filed Nov 26 2025 · 2:58 PM ET Thermopylae Holdings Ltd.PURCHASE 10% owner $742K
343,631 sh × $2.16
Exec Mar 11 2025
Filed Mar 11 2025 · 5:30 PM ET John S. MontalbanoPURCHASE Director $140K
60,000 sh × $2.34
Exec Mar 6 2025
Filed Mar 7 2025 · 5:30 PM ET